Michael Friedman
Michael is a principal and executive in residence at Emerald Bioventures, a life science incubator and venture capital firm. At Emerald Bioventures, Michael plays a key role in company formation, corporate finance and operations within the portfolio. Mr. Friedman comes to Galera with over 20 years of investment banking experience having specialized in healthcare M&A, leveraged finance and capital markets at firms such as Bank of America, Merrill Lynch, Jefferies and Ladenburg. He has executed over $40 billion in M&A and capital markets transactions. Michael has completed multiple venture rounds, PIPEs, licensing transactions, sellside and buyside M&A, IPOs, debt financings, asset sales and divestitures. He is recognized as one of the leading experts in helping small cap companies from their inception through liquidity events. Mr. Friedman is also known as one of the country’s leading experts in reverse mergers and is continuously sought out for his expertise. Michael has an MBA from the University of Chicago and a BBA from the University of Wisconsin.